Biopharmaceuticals. Official position of Russian Association of Endocrinologists
https://doi.org/10.14341/2072-0351-830
Abstract
Some of the glucose-lowering drugs are biopharmaceuticals. This letter states the official position of the Russian Association of Endocrinologists about the treatment with biopharmaceuticals of patients with endocrine disorders. This topic has not yet been
adequately reflected in the legal regulation of the drug market in the Russian Federation .
About the Author
Editorial team Diabetes Mellitus
Russian Association of Endocrinologists, Moscow
Russian Federation
Russian Federation
Review
For citations:
Biopharmaceuticals. Official position of Russian Association of Endocrinologists. Diabetes mellitus. 2013;16(3):121-122. (In Russ.) https://doi.org/10.14341/2072-0351-830
Views:
654
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
